SCHEMBL1844645

SCHEMBL1844645

CC[C@H](Br)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2326753 1.00
SCHEMBL532563 1.00
SCHEMBL28380729 0.91 ZDHHC7 (0.50)
SCHEMBL27965522 0.87 ZDHHC7 (0.47)
SCHEMBL1008732 0.81 ZDHHC7 (0.50)
SCHEMBL1415280 0.81 ZDHHC7 (0.54)
SCHEMBL5965786 0.81 ZDHHC7 (0.65)
SCHEMBL1415237 0.81 ZDHHC7 (0.65)
SCHEMBL10552946 0.81 ZDHHC7 (0.39)
SCHEMBL2199874 0.81 ZDHHC7 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110799495-B Synthesis method of levetiracetam 浙江华海药业股份有限公司 2022-12-13 CN disclosed
CN-110799495-A Synthesis method of levetiracetam 浙江华海药业股份有限公司 2020-02-14 CN disclosed
EP-2325185-A1 Plk inhibitor GPC Biotech AG (DE) 2011-05-25 EP disclosed